Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-05-21

Clinical Trial Update: The Effect of Remifentanil on Established Capsaicin-Induced Hyperalgesia in Human Volunteers [Phase 4]

View source ↗

Summary

Phase 4 trial assessing whether remifentanil alters capsaicin-induced hyperalgesia in healthy volunteers; current status is not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remifentanil (remifentanil)

Snippet

Sponsor: Medical University of Vienna | Conditions: Hyperalgesia | Phase 4 | Status: UNKNOWN